Frequency depends on the injection type, your goals, and provider recommendations
Morales J, Handelsman Y
While large-scale randomized controlled trials (RCTs) have focused on higher-dose protocols for regulatory approval, a growing number of physicians are reporting excellent results at significantly lower doses , especially in individuals who are metabolically healthy or seeking lifestyle optimization rather than aggressive weight loss
measured lipid peroxide content in plasma LDL from patients with various cardiovascular and metabolic conditions, including T2DM (53)
Key highlights Tirzepatide (also known by FDA-approved brand names Mounjaro and Zepbound) is a dual receptor agonist (GLP-1/GIP) that helps reduce appetite, control blood sugar, and promote greater weight loss than single receptor GLP-1 receptor agonists, such as semaglutide
The Thighs Your thighs are another fantastic, easily accessible option